Maryam Hassan Al-Zahrani

5PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pacific Peoples theory of change models for healthCheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 28, 2025
Reticuline and Coclaurine Exhibit Vitamin D Receptor-Dependent Anticancer and Pro-Apoptotic Activities in the Colorectal Cancer Cell Line HCT116.

Hind A Alghamdi, Sahar S Alghamdi, Maryam Hassan Al-Zahrani

|Jan 21, 2023
T Cells Immunophenotyping and CD38 Overexpression as Hallmarks of the Severity of COVID-19 and Predictors of Patients' Outcomes.

Nesrin I Tarbiah, Nuha A Alkhattabi, Abdullah J Alsahafi

|Aug 26, 2022
Accelerating Effect of Cucurbita pepo L. Fruit Extract on Excisional Wound Healing in Depressed Rats Is Mediated through Its Anti-Inflammatory and Antioxidant Effects.

Hailah M Almohaimeed, Maryam Hassan Al-Zahrani, Mohammed Saad Almuhayawi

|Jul 27, 2022
Novel Design of RNA Aptamers as Cancer Inhibitors and Diagnosis Targeting the Tyrosine Kinase Domain of the NT-3 Growth Factor Receptor Using a Computational Sequence-Based Approach.

Ashraf M Muhammad, Ali Zari, Nouf H Alsubhi

|Dec 10, 2021
Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises.

Mourad Assidi, Fatimah M Yahya, Maryam H Al-Zahrani

Pageof 1

Frequent Collaborators

3 joint publications

Rana Abdullah Alghamdi

1 joint publications

Mourad Assidi

1 joint publications

Fatimah M Yahya

1 joint publications

Aisha Elaimi